We are live on
!
Find out more
enGene Therapeutics Warrants
ENGNW
ENGNW
15 hedge funds and large institutions have $3.7M invested in enGene Therapeutics Warrants in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
36.39% more ownership
Funds ownership: 9.34% → 45.73% (+36%)
27% more capital invested
Capital invested by funds: $2.91M → $3.7M (+$791K)
7% more funds holding
Funds holding: 14 → 15 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
–
Reduced
1
Closed
–
Calls
$57K
Puts
–
Net Calls
+$57K
Net Calls Change
+$16K
Top Buyers
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$70 |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.58K |